Related Experiment Video
Updated: May 12, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer
A M Richter1, S K Walesch, P Würl
1Institute for Genetics, Justus-Liebig-University, Universities of Giessen and Marburg Lung Center, Member of the German Center for Lung Research, Giessen, Germany.
Abstract:
The Ras association domain family (RASSF) comprises a group of tumor suppressors that are frequently epigenetically inactivated in various tumor entities and linked to apoptosis, cell cycle control and microtubule stability. In this work, we concentrated on the newly identified putative tumor suppressor RASSF10. Methylation analysis reveals RASSF10 promoter hypermethylation in lung cancer, head and neck (HN) cancer, sarcoma and pancreatic cancer. An increase in RASSF10 methylation from normal tissues, primary tumors to cancer cell lines was observed. Methylation was reversed by 5-aza-2'-deoxycytidine treatment leading to reexpression of RASSF10. We further show that overexpression of RASSF10 suppresses colony formation in cancer cell lines. In addition, RASSF10 is upregulated by cell-cell contact and regulated on promoter level as well as endogenously by forskolin, protein kinase A (PKA) and activator Protein 1 (AP-1), linking RASSF10 to the cAMP signaling pathway. Knockdown of the AP-1 member JunD interfered with contact inhibition induced RASSF10 expression. In summary, we found RASSF10 to be epigenetically inactivated by hypermethylation of its CpG island promoter in lung, HN, sarcoma and pancreatic cancer. Furthermore, our novel findings suggest that tumor suppressor RASSF10 is upregulated by PKA and JunD signaling upon contact inhibition and that RASSF10 suppresses growth of cancer cells.
Insights
The Ras association domain family 10 (RASSF10) tumor suppressor is epigenetically silenced by promoter hypermethylation in lung, head and neck, sarcoma, and pancreatic cancers. RASSF10 reexpression suppresses cancer cell growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- The Ras association domain family (RASSF) includes tumor suppressors involved in apoptosis, cell cycle control, and microtubule stability.
- Epigenetic inactivation is common in various cancers, affecting tumor suppressor gene function.
- RASSF10 is a newly identified member of the RASSF family with potential tumor suppressor roles.
Purpose of the Study:
- To investigate the epigenetic status and functional role of the putative tumor suppressor RASSF10 in cancer.
- To determine the prevalence of RASSF10 promoter hypermethylation in different cancer types.
- To explore the regulatory mechanisms and signaling pathways influencing RASSF10 expression.
Main Methods:
- Analysis of RASSF10 promoter methylation in normal tissues, primary tumors, and cancer cell lines.
- Treatment with 5-aza-2'-deoxycytidine to assess methylation reversal and gene reexpression.
- Overexpression studies to evaluate RASSF10's effect on cancer cell colony formation.
- Investigation of RASSF10 regulation by cell-cell contact, forskolin, protein kinase A (PKA), and Activator Protein 1 (AP-1) signaling.
Main Results:
- RASSF10 promoter hypermethylation was identified in lung, head and neck (HN) cancer, sarcoma, and pancreatic cancer.
- RASSF10 methylation levels increased from normal tissues to primary tumors and cancer cell lines.
- 5-aza-2'-deoxycytidine treatment reversed methylation and restored RASSF10 expression.
- RASSF10 overexpression suppressed colony formation in cancer cell lines.
- RASSF10 expression is upregulated by cell-cell contact and regulated by PKA and AP-1 signaling via the cAMP pathway.
- Knockdown of JunD, an AP-1 member, interfered with contact inhibition-induced RASSF10 expression.
Conclusions:
- RASSF10 acts as a tumor suppressor epigenetically inactivated by promoter hypermethylation in multiple cancer types.
- RASSF10 plays a role in contact inhibition and its expression is linked to the cAMP signaling pathway.
- RASSF10 upregulation by PKA and JunD signaling upon contact inhibition suggests a novel tumor suppressive mechanism.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
